GRP
PBYI icon

Global Retirement Partners’s Puma Biotechnology PBYI Stock Holding History

Global Retirement Partners’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
+1,492
New +$10.9K ﹤0.01% 3303
2025
Q4 		$8.88K Hold
1,492
– – ﹤0.01% 3205
2025
Q3 		$7.92K Hold
1,492
– – ﹤0.01% 2785
2025
Q2 		$5.12K Buy
+1,492
New +$4.76K ﹤0.01% 2900

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Retirement Partners's PBYI Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Puma Biotechnology (PBYI) in Q2 2026: 1,492 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #3303 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in PBYI as recently as Q4 2025.

Global Retirement Partners first reported a position in PBYI in Q2 2025 and has held it in 4 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Global Retirement Partners held 1,492 shares of Puma Biotechnology worth $12.1K as of Q2 2026.
  • Puma Biotechnology was a new Global Retirement Partners position in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3303 holding.
  • Global Retirement Partners first reported a position in Puma Biotechnology in Q2 2025 and has held it in 4 quarters since.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.